Cytoplasm News and Research

RSS
What do we know about the SARS-CoV-2 vaccines so far?

What do we know about the SARS-CoV-2 vaccines so far?

Study shows why children of obese mothers have propensity to develop metabolic diseases

Study shows why children of obese mothers have propensity to develop metabolic diseases

Mutations in the SARS-CoV-2 receptor-binding domain analyzed

Mutations in the SARS-CoV-2 receptor-binding domain analyzed

Treating 'fetus as the patient' could reduce the incidence of pre-term labor and premature birth

Treating 'fetus as the patient' could reduce the incidence of pre-term labor and premature birth

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

New tests may help reveal the transcriptome of SARS-CoV-2 and predict disease course

New tests may help reveal the transcriptome of SARS-CoV-2 and predict disease course

Researchers identify link between ALS and accumulation of DNA-RNA hybrids in the genome

Researchers identify link between ALS and accumulation of DNA-RNA hybrids in the genome

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Nuclear DICER complex disrupts cytoplasmic microRNAome in glioblastoma cancer cells

Nuclear DICER complex disrupts cytoplasmic microRNAome in glioblastoma cancer cells

Study opens the way for a potential new cure for children with hard-to-treat neuroblastoma

Study opens the way for a potential new cure for children with hard-to-treat neuroblastoma

CytoDel successfully delivers neuronal antibody in animal models of botulism

CytoDel successfully delivers neuronal antibody in animal models of botulism

Researchers discover how chromosomal instability allows cancer cells to avoid immune defenses

Researchers discover how chromosomal instability allows cancer cells to avoid immune defenses

Research may lead to better treatment and vaccines for Ebola, COVID-19

Research may lead to better treatment and vaccines for Ebola, COVID-19

Novel amorphous nanoparticles can efficiently and selectively kill cancer cells

Novel amorphous nanoparticles can efficiently and selectively kill cancer cells

Researchers develop new nanoparticle that efficiently and selectively kills cancer cells

Researchers develop new nanoparticle that efficiently and selectively kills cancer cells

Errant DNA triggers immune system response against cancer

Errant DNA triggers immune system response against cancer

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Study unlocks some muscle cell secrets

Study unlocks some muscle cell secrets

D614/G614 variants of SARS-CoV-2 affect neuronal transmission; G614 better at membrane fusion

D614/G614 variants of SARS-CoV-2 affect neuronal transmission; G614 better at membrane fusion